These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Screening a library of 1600 adamantyl ureas for anti-Mycobacterium tuberculosis activity in vitro and for better physical chemical properties for bioavailability. Scherman MS; North EJ; Jones V; Hess TN; Grzegorzewicz AE; Kasagami T; Kim IH; Merzlikin O; Lenaerts AJ; Lee RE; Jackson M; Morisseau C; McNeil MR Bioorg Med Chem; 2012 May; 20(10):3255-62. PubMed ID: 22522007 [TBL] [Abstract][Full Text] [Related]
9. Bioisosteric substitution of adamantane with bicyclic lipophilic groups improves water solubility of human soluble epoxide hydrolase inhibitors. Burmistrov V; Morisseau C; Karlov D; Pitushkin D; Vernigora A; Rasskazova E; Butov GM; Hammock BD Bioorg Med Chem Lett; 2020 Sep; 30(18):127430. PubMed ID: 32736212 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo metabolism of N-adamantyl substituted urea-based soluble epoxide hydrolase inhibitors. Liu JY; Tsai HJ; Morisseau C; Lango J; Hwang SH; Watanabe T; Kim IH; Hammock BD Biochem Pharmacol; 2015 Dec; 98(4):718-31. PubMed ID: 26494425 [TBL] [Abstract][Full Text] [Related]
11. 1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain. Rose TE; Morisseau C; Liu JY; Inceoglu B; Jones PD; Sanborn JR; Hammock BD J Med Chem; 2010 Oct; 53(19):7067-75. PubMed ID: 20812725 [TBL] [Abstract][Full Text] [Related]
12. Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors. Hwang SH; Morisseau C; Do Z; Hammock BD Bioorg Med Chem Lett; 2006 Nov; 16(22):5773-7. PubMed ID: 16949285 [TBL] [Abstract][Full Text] [Related]
14. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors. Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357 [TBL] [Abstract][Full Text] [Related]
15. 1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties. Kim IH; Tsai HJ; Nishi K; Kasagami T; Morisseau C; Hammock BD J Med Chem; 2007 Oct; 50(21):5217-26. PubMed ID: 17894481 [TBL] [Abstract][Full Text] [Related]
16. Structure-based optimization of the piperazino-containing 1,3-disubstituted ureas affording sub-nanomolar inhibitors of soluble epoxide hydrolase. Huang SX; Cao B; Morisseau C; Jin Y; Hammock BD; Long YQ Medchemcomm; 2012 Mar; (3):379-384. PubMed ID: 25225606 [TBL] [Abstract][Full Text] [Related]
17. The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase. Li HY; Jin Y; Morisseau C; Hammock BD; Long YQ Bioorg Med Chem; 2006 Oct; 14(19):6586-92. PubMed ID: 16784862 [TBL] [Abstract][Full Text] [Related]
18. Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ. Nayeem MA; Pradhan I; Mustafa SJ; Morisseau C; Falck JR; Zeldin DC Am J Physiol Regul Integr Comp Physiol; 2013 Jan; 304(1):R23-32. PubMed ID: 23152114 [TBL] [Abstract][Full Text] [Related]